EpiVario Competitors and Similar CompaniesClear all
EpiVario's competitors and similar companies include ACADIA Pharmaceuticals, Alector, Stalicla and Suven Life Sciences.
 EpiVario EpiVario is a pharmaceutical company that develops treatments for memory-related psychiatric disorders. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  Stalicla Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders. |  Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. | |
Founding Date | Founding Date 2017 | Founding Date 1993 | Founding Date 2013 | Founding Date 2017 | Founding Date 1989 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ | Locations San Diego, US HQ Princeton, US | Locations San Francisco, US HQ | Locations Genève, CH HQ | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US |
Employees | Employees 5 | Employees 513 | Employees 2382% decrease | Employees 264% increase | Employees 141 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) 495.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹71.1m (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $982.5m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ₹210.4m (FY, 2026) |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income ($142.9m) (FY, 2025) | Net income N/A | Net income (₹2.8b) (FY, 2026) |
Funding | |||||
Latest funding round | Latest funding round $ 445k (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 8m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 445k | Total funding raised $ 770.8m | Total funding raised $ 194.5m | Total funding raised $ 18.2m | Total funding raised $ 32m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View companyStalicla
HQ
Genève, CH
Employees
26↑ 4% increase
Stalicla is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
View companySuven Life Sciences
HQ
Hyderabad, IN
Employees
141
Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS.
View company